Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,004 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

NCT00217438

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Rochester Rochester, New York, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma

NCT01085214

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
  • Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

NCT02221479

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 392105 Kamogawa-Shi, Japan
  • Investigational Site Number 392103 Kyoto, Japan
  • Investigational Site Number 392102 Nagoya, Japan
  • Investigational Site Number 392104 Okayama, Japan
View Trial Details
Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +14 more
Locations
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHU de Nancy Nancy, France
  • Service de Médecine Interne - CHU de Saint Etienne Saint-Etienne, France
  • Service de rhumatologie - CHU de Saint Etienne Saint-Etienne, France
View Trial Details
Completed

Allo SCT in Amyloidosis Non-interventional Study

NCT02257905

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • CHRU Limoges Limoges, France
  • University Hospital Eppendorf Hamburg, Germany
  • University of Heidelberg Heidelberg, Germany
  • University Hospital Basel, Switzerland
View Trial Details

Related conditions